| Gland Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543245 |
NSE Symbol : GLAND |
P/E(TTM) : 24.94 |
|
ISIN Demat : INE068V01023 |
Div & Yield% : 1.03 |
EPS(TTM) : 70.19 |
|
Book Value(₹) : 610.02 |
Market Cap(₹Cr) : 28,841.44 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,116.15 | 4,167.43 | 3,616.53 | 4,400.71 | 3,462.88 |
| Other Income | 215.08 | 166.67 | 240.46 | 223.94 | 134.78 |
| Stock Adjustments | -130.25 | -87.43 | 46.92 | -36.69 | 273.49 |
| Total Income | 4,200.98 | 4,246.67 | 3,903.91 | 4,587.96 | 3,871.15 |
| EXPENDITURE : | |||||
| Raw Materials | 1,600.35 | 1,732.88 | 1,732.34 | 2,072.53 | 1,765.36 |
| Power and Fuel Cost | 120.38 | 117.20 | 124.84 | 95.05 | 74.59 |
| Other Manufacturing Expenses | 188.89 | 186.92 | 153.84 | 137.19 | 130.84 |
| Selling and Administration Expenses | 155.54 | 175.97 | 189.65 | 177.43 | 128.44 |
| Miscellaneous Expenses | 39.10 | 48.31 | 100.99 | 32.61 | 23.51 |
| Employee Benefit Expenses | 439.02 | 409.95 | 399.70 | 338.57 | 311.36 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,657.70 | 1,575.44 | 1,202.55 | 1,734.58 | 1,437.04 |
| Interest | 22.84 | 7.84 | 7.41 | 5.24 | 3.41 |
| Gross Profit | 1,634.86 | 1,567.60 | 1,195.14 | 1,729.34 | 1,433.63 |
| Depreciation | 169.27 | 162.11 | 146.74 | 110.30 | 98.78 |
| Profit Before Tax | 1,465.59 | 1,405.49 | 1,048.40 | 1,619.04 | 1,334.85 |
| Current Tax | 366.71 | 337.49 | 275.38 | 392.88 | 337.73 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 9.12 | 24.68 | -2.80 | 14.01 | 0.12 |
| Reported Net Profit | 1,089.75 | 1,043.33 | 775.83 | 1,212.16 | 997.01 |
| Extraordinary Items | 0.97 | -0.39 | -39.55 | 3.22 | 0.02 |
| Adjusted Net Profit | 1,088.78 | 1,043.72 | 815.38 | 1,208.94 | 996.99 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 7,054.03 | 6,010.70 | 5,234.88 | 4,022.72 | 3,025.72 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 329.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 7,814.28 | 7,054.03 | 6,010.70 | 5,234.88 | 4,022.72 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,800.00 | 2,000.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 18.00 | 20.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 66.14 | 63.34 | 47.11 | 73.78 | 60.95 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 592.08 | 546.13 | 482.90 | 435.68 | 360.86 |
| Book Value(Adj)-Unit Curr | 592.08 | 546.13 | 482.90 | 435.68 | 360.86 |